Medical Weight Loss for Cincinnati, Ohio Residents

Cincinnati, Ohio residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Cincinnati through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

No clinic to drive to in Cincinnati: Dr. Anjmun Sharma reviews your health by video, and your compounded semaglutide or tirzepatide ships straight to your Ohio address. Nothing to pick up, no waiting room, no local office needed. Doctor review just $119 (medication separate).

Why Cincinnati Residents Choose New Hope Weight Loss

If past attempts left you frustrated, Cincinnati, the difference here is structure and honesty. There is a real physician, Dr. Anjmun Sharma, behind your plan, a transparent price you can see up front, and a program that meets you by telehealth instead of dragging you across Ohio for every visit. Compounded semaglutide and tirzepatide are not magic and they are not FDA-approved, but paired with steady medical guidance they give a lot of people a genuine path forward.

Cincinnati is served through telehealth from our Costa Mesa, California clinic. The full program runs by secure video, with medication shipped to your Cincinnati address.

For anyone in Cincinnati, Ohio, the distance to Costa Mesa simply does not matter, because Dr. Anjmun Sharma manages your entire program by video and message rather than in person. We care for patients throughout Downtown, Over-the-Rhine, Hyde Park, Clifton, and the greater Cincinnati area. Our team supports you in English and Spanish, so you can ask questions in the language you are most comfortable with no matter where in Cincinnati you are.

Whether you live in central Cincinnati or out toward the edges of Ohio, you see the same physician, Dr. Anjmun Sharma, and pay the same flat pricing with no distance surcharge. Because every Cincinnati visit happens by video, there is no local office to drive to and no travel cost added to your $119 review. New Hope Weight Loss serves patients throughout Ohio entirely by telehealth from our Costa Mesa, California clinic, bringing physician-supervised programs to your home without an office visit.

GLP-1 Weight Loss Programs Available

Semaglutide: the 90-Day Metabolic Reset

If you live in Cincinnati and want a clear starting point, this is it. Semaglutide, the active ingredient also used in Wegovy and Ozempic, costs from $166 per month or $499 for the 90-day program. Branded-drug trials showed roughly 15 to 17 percent average weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, so results vary.

Tirzepatide: the dual GLP-1 and GIP option

For patients who want a second lever, tirzepatide starts at $233 per month and acts on both GLP-1 and GIP receptors. Up to 22.5 percent body-weight loss appeared in branded-drug trials at qualifying doses, which is not typical. It shares an active ingredient with Mounjaro and Zepbound.

A $119 physician review is required up front. Medication billed separately. HSA, FSA, Klarna, and Affirm are accepted.

How Telehealth Works for Cincinnati

The path from curious to treated is short, and it all runs through your screen. People in Cincinnati start by completing a health-and-weight intake quiz online. Dr. Anjmun Sharma reviews every answer and meets you over secure video, usually within 48 hours, to talk through whether a compounded GLP-1 like semaglutide or tirzepatide fits your goals and history. When she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Cincinnati home in cold-pack packaging designed to keep it stable. After that, you and Dr. Sharma stay connected through video follow-ups, so your progress is supported from any corner of .

Frequently Asked Questions, Cincinnati

Is there somewhere in Cincinnati I can visit New Hope Weight Loss?

There is no physical office in Cincinnati. We work from a single clinic in Costa Mesa, California, and care for Cincinnati, Ohio patients by telehealth. Your candidacy for a compounded GLP-1 plan is confirmed when Dr. Anjmun Sharma reviews your health information during an online video appointment.

Will Cincinnati patients have to make any in-person trips?

No trips are necessary. We provide care to Cincinnati completely through telehealth, covering consults, follow-up visits, and ongoing support remotely. Once Dr. Sharma signs off, your compounded semaglutide or tirzepatide is delivered to Cincinnati in cold-pack shipping that preserves the correct temperature.

What does the program cost a Cincinnati patient?

Budget $119 for the physician visit. Semaglutide is priced from $166 monthly or $499 for 90 days, and tirzepatide from $233 monthly. The medication is a separate line item. We accept HSA, FSA, Klarna, and Affirm, and no distance surcharge is added for patients located in Cincinnati.

What areas of Cincinnati do you serve?

We serve patients from across Cincinnati by telehealth, including Downtown, Over-the-Rhine, Hyde Park, Clifton, and the greater Cincinnati area.

Does the program cost more for Cincinnati patients because of shipping?

No. Pricing is the same nationwide: a $119 physician visit and compounded semaglutide from $166/month, medication billed separately. Cold-pack shipping to Cincinnati is part of the standard process, there is no distance surcharge.

Cincinnati Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Cincinnati, Ohio by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.